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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYMammalian neural stem/progenitor cells (NSPCs) sequentially generate neurons and glia during CNS development. Here we identified
miRNA-153 (miR-153) as a modulator of the temporal regulation of NSPC differentiation. Overexpression (OE) of miR-153 delayed the
onset of astrogliogenesis andmaintained NSPCs in an undifferentiated state in vitro and in the developing cortex. The transcription fac-
tors nuclear factor I (NFI) A and B, essential regulators of the initiation of gliogenesis, were found to be targets of miR-153. Inhibition of
miR-153 in early neurogenic NSPCs induced precocious gliogenesis, whereas NFIA/B overexpression rescued the anti-gliogenic pheno-
types induced by miR-153 OE. Our results indicate that miR-mediated fine control of NFIA/B expression is important in the molecular
networks that regulate the acquisition of gliogenic competence by NSPCs in the developing CNS.INTRODUCTION
Development of the vertebrate CNS is directed by the gen-
eration of various types of neurons and glia from multipo-
tent neural stem/progenitor cells (NSPCs) in spatially and
temporally regulated patterns (Okano and Temple, 2009).
The temporal regulation of NSPC fate largely depends on
the intrinsic regulation of cellular differentiation potential
(Miller and Gauthier, 2007; Okano and Temple, 2009). For
instance, NSPCs in early gestation cannot differentiate into
astrocytes because they lack the competency to respond to
gliogenic differentiation signals, including signals from the
interleukin-6 (IL-6)/Janus kinase (JAK)/signal transducer
and activator of transcription (STAT) pathway (Koblar
et al., 1998; Nakashima et al., 1999), the bone morpho-
genic protein 2/4 (BMP2/4)/SMAD pathway (Gross et al.,
1996; Nakashima et al., 2001), and the Notch signaling
pathway (Ge et al., 2002; Grandbarbe et al., 2003). There-
fore, gliogenesis starts during late embryonic stages after
the acquisition of gliogenic competence by NSPCs to
respond to these assorted signals at midgestation. There-
fore, they generate neurons first in the developing brain,
followed by glia.
The neurogenic-to-gliogenic transition of NSPCs is prob-
ably governed by a multi-layered system. The epigenetic
status of astrocyte-specific (Takizawa et al., 2001) and
neurogenic genes changes during development (Hirabaya-
shi et al., 2009; Kishi et al., 2012; Pereira et al., 2010), crit-
ically determining NSPC responsiveness to extrinsic differ-
entiation signals. Several transcription factors regulate the
acquisition of gliogenic competence. For example, nuclearStem Cellfactor IA (NFIA) acts as a key regulator for the initiation of
gliogenesis (das Neves et al., 1999; Deneen et al., 2006;
Kang et al., 2012). Nfia is induced by the high-mobility
group (HMG) box family member SOX9 and forms a
SOX9/NFIA complex to control the induction of a subset
of glial-specific genes (Kang et al., 2012). Moreover, NFIA
is required for Notch signaling-induced demethylation of
the glial fibrillary acidic protein (Gfap) gene promoter in
NSPCs (Namihira et al., 2009). Our group has reported pre-
viously that chicken ovalbumin upstream promoter-tran-
scription factor (COUP-TF) I and COUP-TFII are triggers
of the neurogenic-to-gliogenic competence switch in
NSPCs (Naka et al., 2008). However, in vitro knockdown
(KD) of Coup-tfI/II in NSPCs did not substantially affect
the expression levels of Nfia (Naka et al., 2008). Therefore,
multiple transcriptional regulatory cascades act together to
control NSPC acquisition of gliogenic competence.
MicroRNAs (miRNAs) are small endogenous non-coding
RNAs found in many different organisms, including ani-
mals that regulate gene expression mainly at the post-tran-
scriptional level (Bartel, 2004). In vertebrates, miRNAs
base-pair with target sequences typically located within
the 30 UTR of target mRNAs by using 50 ‘‘seed’’ regions.
Furthermore, miRNAs stimulate RNA-silencing complexes
to induce degradation, destabilization, and/or transla-
tional inhibition of target mRNAs (Bartel, 2009; Guo
et al., 2010; Huntzinger and Izaurralde, 2011) and are
seemingly involved in almost all cellular events, including
the determination of cell fate (Ebert and Sharp, 2012;
Friedman et al., 2009). In the developing mammalian
CNS, various miRNAs participate in the control of neuralReports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Authors 365
stem cell self-renewal, proliferation, and differentiation
(Balzer et al., 2010; Cimadamore et al., 2013; Li and Jin,
2010; Naka-Kaneda et al., 2014; Neo et al., 2014; Qureshi
and Mehler, 2012; Shibata et al., 2011; Visvanathan
et al., 2007; Yoo et al., 2009; Zhao et al., 2009).
This study identifies miR-153 as a regulator of the initia-
tion of gliogenesis in the developing CNS. Although miR-
153 is implicated in synaptic function, neurodegenerative
disorders, and fetal ethanol exposure (Chi et al., 2009; Dox-
akis, 2010; Liang et al., 2012; Tsai et al., 2014; Wei et al.,
2013), no reports to date have described a function for
miR-153 in gliogenesis by NSPCs. Here we demonstrate
that miR-153 inhibits the acquisition of gliogenic compe-
tence in NSPCs by targeting Nfia/b mRNAs.RESULTS
Identification of Anti-Gliogenic miRNAs in NSPCs
Because the NFI transcription factors have been shown to
be key regulators of gliogenesis (Shu et al., 2003; Deneen
et al., 2006; Barry et al., 2008), we utilized this pathway
to identifymiRNAs involved in the regulation of the neuro-
genesis-to-gliogenesis switch by NSPCs. We focused on
miRNAs with expression levels that were differentially
regulated downstream of NFIA and established a mouse
embryonic stem cell (ESC) line that expresses NFIA in
a doxycycline (Dox)-dependent manner (the so-called
‘‘tet-off’’ system; Figures S1A and S1B). We also took advan-
tage of a mouse pluripotent stem cell culture system that
recapitulates the temporal specification of NSPCs (Miura
et al., 2009; Naka-Kaneda et al., 2014; Naka et al., 2008;
Okada et al., 2008).
To confirm the gliogenic role and cell-autonomous ac-
tions of NFIA in the promotion of gliogenesis, we co-
cultured multipotent NSPCs derived from tet-off ESCs
and wild-type (WT) ESCs to form aggregated and mixed
(WT/NFIA-mix) neurospheres (Figure S1C). The differenti-
ation phenotype of the neurospheres was then assessed
after the induction of exogenous NFIA expression by with-
drawing Dox. NFIA overexpression (OE) promoted astro-
gliogenesis only after at least one passage of ESC-generated
primary neurospheres (PNs) derived via embryoid body
(EB) formation (data not shown). Therefore, the following
in vitro functional studies of ESC-derived NSPCs were car-
ried out using secondary or tertiary neurospheres (SNs
and TNs). As expected, NFIA OE significantly facilitated as-
trocytic differentiation and suppressed neuronal differenti-
ation ofNSPCs inWT/NFIA-mix neurospheres (Figures S1D
and S1E). On the other hand, intriguingly, we did not
observe any significant increase in astrocytic differentia-
tion but, rather, inhibition of neuronal differentiation
of NSPCs derived from neurospheres composed of only366 Stem Cell Reports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The ANFIA OE cells (Figures S1D and S1E). This phenotypic dif-
ferencemay be due to a difference in the amount of endog-
enous gliogenic factors such as cardiotrophin-1, which is
secreted fromneurons (Barnabe´-Heider et al., 2005). No sig-
nificant differences were observed betweenWTcells within
WT/NFIA-mix neurospheres and NFIA knockin cells in the
presence of Dox in terms of their neuronal and glial differ-
entiation phenotypes (Figures S1D and S1E).
Next, global miRNA expression patterns were compared
between control and NFIA OE cells isolated from WT/
NFIA-mix neurospheres. We identified ten candidate miR-
NAs (with 11 probes) that were expressed in a temporally
regulated manner during the in vitro development of
ESC-derived NSPCs and showed altered expression by
NFIA OE in the manner of accelerated temporal changes
(Figures 1A and 1B; Table S1; Supplemental Experimental
Procedures). To assess the function of these miRNAs, lenti-
viral vectors expressing eachmiRNAwere generated and in-
fected into SNs, followed by induction of differentiation
(Figure 1A). Of these miRNAs, only OE of miR-124, miR-
153, and miR-219 significantly decreased the proportion
of GFAP-positive (+) astrocytes (Figures 1C and 1D). How-
ever, only miR-124 OE significantly increased the appear-
ance of bIII-TUBULIN+ neurons. All three miRNAs were
highly expressed in PNs and downregulated during neuro-
sphere passage and by NFIA OE (Table S1). Of note, our
screening did not identify any miRNAs promoting astro-
gliogenesis. The miR-124 OE phenotype is consistent
with previous results showing that miR-124 is crucial for
neurogenesis (Kawahara et al., 2012). However, the roles
of miR-153 and miR-219 in mammalian NSPCs have not
yet been elucidated. Therefore, we focused on miR-153
and miR-219 for further investigation.
To confirm the anti-gliogenic function of miR-153 and
miR-219, we examined the differentiation phenotype of
the more gliogenic TNs after lentiviral transduction at the
time of plating for SN formation. Under these conditions,
miR-153 OE, but not miR-219 OE, still significantly in-
hibited astrocytic differentiation (Figures 1E and 1F).
Therefore, miR-124, miR-153, and miR-219 differentially
influence the timing of gliogenesis in developing NSPCs.
Spatiotemporal Expression of miR-153 in Developing
NSPCs
To determine whether miR-153 and miR-219 could inhibit
gliogenesis during the neurogenic phase of cortical devel-
opment, we analyzed their expression patterns in the
developing mouse CNS by detecting mature miRNAs by
in situ hybridization (ISH) with locked nucleic acid (LNA)
probes. On embryonic days (E) 9.5 and E10.5, expression
of miR-153 was broadly detected throughout the CNS,
including in the ventricular zone (VZ) (Figures 2A and
2B). In the E14.5 forebrain, miR-153 was observeduthors
Figure 1. Identification of Anti-Gliogenic
miRNAs
(A) Schematic of the screening process
for miRNAs involved in the temporal spec-
ification of NSPCs. PNs generate only
neurons. SNs and TNs can also generate
astrocytes. Left: Venn diagram depicting
the overlap between miRNAs upregulated
(>1.5-fold) by NFIA OE in SNs and miRNAs
with a >1.5-fold higher expression level in
late versus early NSPCs. Right: Venn dia-
gram depicting the overlap between miR-
NAs downregulated (<0.75-fold) by NFIA
OE in SNs and miRNAs with a >1.5-fold
higher expression level in early versus late
NSPCs (see Supplemental Experimental
Procedures). Ten miRNAs with 11 probes
extracted by the comparative analysis were
functionally analyzed by OE via lentiviral
vectors in SNs.
(B) Heatmap of the ten candidate miRNAs
differentially expressed during the passage
of ESC-derived neurospheres and responsive
to NFIA OE. Expression levels are shown
relative to that in PNs.
(C and D) OE of miR-124, miR-153, or miR-
219 inhibits astrocytic differentiation from
SNs. Percentages of b-III TUBULIN+ and
GFAP+ cells among the lentivirus-infected
GFP+ cells are shown (n = 4).
(E and F) OE of miR-153 (but not miR-219) in TNs inhibits astrocytic differentiation (n = 3). Lentiviruses were transduced at the time of
plating for SN formation.
Data represent the means ± SD (*p < 0.05, **p < 0.01 versus miR-LacZ control; n = number of independent experiments). Scale bars,
50 mm.throughout the ventral region, including the VZ and the
cortical plate (CP), but was only faintly detected in the
cortical VZ (Figure 2C). In contrast, miR-219 was found in
the E9.5 mesencephalon, rhombencephalon, and spinal
cord but not in the prosencephalon (Figure S2). Because
miR-153 displayed stronger anti-gliogenic potential (Fig-
ures 1E and 1F) and miR-219 is not expressed in the devel-
oping forebrain/telencephalon/cortex, we focused only on
the role of miR-153 in the remainder of this study.
Next we verified the expression levels of miR-153 in ESC-
derivedNSPCs at different developmental stages in vitro by
RT-qPCR analysis. Consistent with the miRNA array data
(Figure 1B), miR-153 expression levels decreased as the
number of neurosphere passages increased (Figure S3).
We also analyzed miR-153 expression in NSPCs in the
developingmouse forebrain by RT-qPCR. NSPCs were puri-
fied from Nestin- EGFP transgenic mouse embryos (Kawa-
guchi et al., 2001) via fluorescence-activated cell sorting
(FACS). Compared with the E10.5 telencephalon, miR-
153 expression levels in NSPCs derived from the E14.5Stem Celland E18.5 cortex were significantly attenuated. Neverthe-
less, similar expression levels were maintained in the
E10.5 telencephalon and the E14.5 and 18.5 lateral gangli-
onic eminence (LGE) (Figure 2D), consistent with the
ISH results (Figures 2A–2C). Moreover, because the LGE
and, subsequently, the adult subventricular zone (SVZ)
constantly generate neurons throughout life (Alvarez-
Buylla et al., 2008), these findings indicate that miR-153
expression in NSPCs is related to prolonging the neuro-
genic potential of NSPCs.
Effects of miR-153 on the Acquisition of NSPC
Gliogenic Competence
Although miR-153 OE inhibited astrogliogenesis even in
TNs (Figures 1E and 1F), no significant changes in neuro-
genesis were observed. Therefore, we further analyzed the
fate of miR-153 OE NSPCs after the induction of differenti-
ation in vitro. Differentiated TNs were first immunostained
with antibodies against the SOXB family of transcription
factors (SOX1/2/3), which are specifically expressed inReports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Authors 367
Figure 2. Spatiotemporal Regulation of miR-153 Expression in
the Developing CNS
(A) Whole-mount ISH showing the expression patterns of mature
miR-153 at E9.5 and E10.5. Scale bars, 500 mm.
(B and C) Coronal sections of an E10.5 embryo and E14.5 forebrain
after ISH to mature miR-153. Scale bar, 100 mm.
(D) qPCR analysis of mature miR-153 expression in NSPCs
from Nestin-EGFP mouse embryos at E10.5, E14.5, and E18.5.
Expression levels relative to that in E10.5 telencephalon
are presented as fold differences. Tel, telencephalon; CX,
cortex; LGE, lateral ganglionic eminence. Data represent the
368 Stem Cell Reports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Aundifferentiated neural progenitors (Wood and Episkopou,
1999). The antibody used recognized mainly SOX1/3 but
was faintly reactive against SOX2 (Okada et al., 2004;
Tanaka et al., 2004). Notably, a SOXB+ undifferentiated
population was increased significantly in TNs by miR-153
OE (Figures 3A and 3B).
Next, we asked whether miR-153 OE affects the respon-
siveness of NSPCs to leukemia inhibitory factor (LIF) and
BMP2, two well-known astrogliogenic cytokines. miR-153
OE inhibited astrocytic differentiation of SNs and TNs,
even in the presence of LIF and BMP2 (Figures 3C–3E),
but to a lesser extent than in the absence of the cytokines
(Figures 1C–1F). Unexpectedly, neuronal differentiation
of TNs was increased significantly by miR-153 OE in the
presence of LIF and BMP2. Collectively, these results indi-
cate that miR-153 suppresses the acquisition of gliogenic
competence by NSPCs and maintains their neurogenic po-
tential, although to a limited extent. However, miR-153
may also inhibit the differentiation of committed glial pre-
cursors, even in the face of glial differentiation signals. The
increase in neuronal numbers only in the presence of LIF
and BMP2 may be due to the actions of BMP2 as a neuro-
genic signal. In this regard, BMP can enhance astrocytic
aswell as neuronal differentiation, depending on the devel-
opmental stage (Hegarty et al., 2013; Li et al., 1998). If that
is the case, some of miR-153 OE NSPCs may have main-
tained an early neurogenic status. Alternatively, miR-153
may reduce the sensitivity of NSPCs to various neurogenic
signals, including BMPs.
Suppression of Astrogliogenesis by miR-153 in the
Developing Cortex
To explore the in vivo function of miR-153, we overex-
pressed miR-153 in the developing mouse cortex via lenti-
viral infection and analyzed the fate of the infected NSPCs
by immunohistochemistry with anti-NeuN antibody, a
marker for neurons; anti-Acyl-CoA synthetase, bubblegum
family, member 1 (ACSBG1) antibody, a marker for astro-
cytes (Cahoy et al., 2008); and anti-SOXB antibody, a
marker for undifferentiated progenitors. Lentivirus vectors
were injected into the lateral ventricle (LV) on E12.5, and
brains were fixed on postnatal day 14 (P14). miR-153 OE
significantly increased the number of NeuN+ neurons
and SOXB+ undifferentiated cells in the CP, and signifi-
cantly decreased the number of ACSBG1+ astrocytes (Fig-
ures 4A–4G), similar to the in vitro results of Figure 3.
The SOXB+ miR-153 OE cells in the CP potentially
included undifferentiated glial precursors. Importantly,
miR-153 OE did not influence NSPC migration (Figure S4).means ± the SD (n = 3 embryos; *p < 0.05, **p < 0.01; ns, not
significant).
uthors
Figure 3. Suppression of Gliogenic Com-
petence by miR-153 OE
TNs infected with lentiviruses expressing
miR-LacZ or miR-153 were obtained and
allowed to differentiate as described in
Figure 1.
(A) Immunocytochemical analysis of SOXB
and GFAP expression after induction of dif-
ferentiation.
(B) Percentages of SoxB+ cells among GFP+
cells.
(C) Immunocytochemical analysis of differ-
entiated TNs exposed to LIF (10 ng/ml) and
BMP2 (100 ng/ml) during differentiation.
(D and E) Relative percentages of GFAP+ and
bIII-TUBULIN+ cells among GFP+ cells in
the SNs (D) and TNs (E).
Data in (B), (D), and (E) represent the mean
± SD (n = 3 independent experiments; *p <
0.05, **p < 0.01). Scale bars, 50 mm.Therefore, miR-153 apparently suppresses the differentia-
tion of NSPCs into astrocytes, even after radial migration
in the developing cortex.
The short-term effects of miR-153 OE were also assessed
on NSPC proliferation and neurogenesis in the late embry-
onic cortex by in utero electroporation (IUE) of a miR-153-
expression vector into the E15.5 cortical VZ. Two days after
electroporation, pregnant mice were administered a single
intraperitoneal injection of 5-bromodeoxyuridine (BrdU,
50 mg/kg) and sacrificed 0.5 hr later. miR-153 OE did not
alter the numbers of TBR2 (T-box, brain, 2)+ neuronal pre-
cursors (Englund et al., 2005) or BrdU-labeled S phase cells
(Figures 4H–4J), indicating that miR-153 enhances neither
progenitor proliferation nor neurogenesis in the late em-
bryonic cortex. Collectively, the increase in NeuN+ neu-
rons (Figures 4A–4G)may simply result from the prolonged
maintenance of the neurogenic state of NSPCs.
Nfia and Nfib Are Targets of miR-153
We next set out to identify the direct molecular targets of
miR-153 underlying the miR-153-mediated regulation of
gliogenesis in NSPCs. Because miRNAs generally bind to
and induce the degradation of their target mRNAs (Guo
et al., 2010), global gene expression was compared in
miR-153 OE and NFIA OE NSPCs at different develop-
mental stages (i.e., ESC-derived PNs and TNs) via gene
expression microarray analysis. Candidate genes were
restricted by using web-based miRNA target prediction
programs, and based on their developmental expressionStem Cellpatterns and their loss-of-function (LOF) phenotypes re-
ported previously (Table S3). Interestingly, Nfia and Nfib
were among the seven genes fitting these stringent criteria
(see Supplemental Experimental Procedures), where both
are well-established gliogenic factors (Deneen et al., 2006;
Piper et al., 2014; Steele-Perkins et al., 2005).
Nfi genes were recently identified as potential miR-153-
regulated genes in another system (Tsai et al., 2014). We
confirmed thatNfi genes contain putativemiR-153 binding
sites in their 30 UTRs and that they are upregulated during
passage of ESC-derived neurospheres and downregulated
by miR-153 OE (Figures 5A and 5B; Table S3).
To test whethermiR-153 can indeed decreaseNFIA/B pro-
tein levels in NSPCs, we overexpressed miR-153 in SNs and
TNs as described in Figure 3 and subjected the neuro-
spheres to western blotting analysis with anti-NFIA/B anti-
bodies. Consistent with the microarray data, expression
levels of both Nfia and Nfib were decreased by miR-153
OE (Figure 5C). To examine whether Nfia and Nfib are
directly regulated by miR-153 via their 30 UTRs, we fol-
lowed up with a luciferase reporter gene assay. The full-
length 30 UTR for each gene with or without mutations in
all of the putative miR-153 binding sites was cloned into
a luciferase reporter vector and cotransfected with a miR-
153 expression vector into HEK293A cells. Reporter gene
activities were significantly reduced in miR-153-cotrans-
fected cells compared with cells cotransfected with a con-
trol miR-LacZ expression vector targeting the LacZ gene,
whereas mutations in the putative Nfia/bmiR-153 bindingReports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Authors 369
Figure 4. miR-153-Induced Suppression of Astrogliogenesis in the Developing Cortex
(A, B, and D–G) Lentiviruses expressing miR-LacZ or miR-153 were injected into the E12.5 lateral ventricle.
(A) Infected cells within the P14.5 CP of the frontal cortex were analyzed immunohistochemically for NeuN in differentiated neurons.
(B) ACSBG1 in differentiated astrocytes.
(D–G) SOXB in undifferentiated neural progenitors. Arrowheads indicate non-neuronal cells, including ACSBG1+ astrocytes. Arrows show
cells in enlarged images. miR-153 OE impaired astrocytogenesis, inhibited NSPC differentiation, and increased neurogenesis.
(H–J) IUE of miR-LacZ- or miR-153-expressing vector into cortical NSPCs at E15.5. miR-153 OE did not significantly alter NSPC proliferation
(as assessed by BrdU incorporation) or neurogenesis (as defined by TBR2 expression).
Data in (C) and (J) represent the mean ± SD (n = 3 embryos; *p < 0.05, **p < 0.01). Scale bars, 50 mm.sites decreased the actions of miR-153 (Figure 5D). There-
fore, miR-153 directly downregulates NFIA/B expression.
Nfia and Nfib knockout mice are phenotypically similar,
with significantly reduced GFAP expression in the brain
and an increased undifferentiated progenitor fraction at
the perinatal stage (Barry et al., 2008; Piper et al., 2014;
Steele-Perkins et al., 2005), suggesting a delay in gliogene-
sis. Therefore, we confirmed the contribution of NFIA
and NFIB to astrogliogenesis by performing Nfia or Nfib
KD in mouse cortical NSPCs derived from E14.5 embryos
in vitro. Nfia or Nfib KD was accomplished by lentiviral370 Stem Cell Reports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Avector-mediated expression of the corresponding short
hairpin RNAs (shRNAs), leading to a significant reduc-
tion in astrocytic differentiation of the infected NSPCs
(Figure S5).
Next, we verified thatNfia/b are the downstream effectors
of miR-153 by testing whether NFIA/B OE without the 30
UTR could rescue the anti-gliogenic phenotype of miR-
153 OE in vitro. Co-overexpression of miR-153 and either
NFIA or NFIB in ESC-derived TNs via lentiviral vector intro-
duction partially rescued the astrocytic differentiation that
was inhibited by miR-153 OE versus control Kusabirauthors
Figure 5. Identification of Nfia/b as miR-153 Targets in the Regulation of Gliogenesis
(A) Left: schematic view of putative miR-153 binding sites in Nfia/b mRNAs. Right: miR-153 sequences and complementary binding sites
in Nfia/b 30 UTRs. Seed sequences and complementary sequences are boxed in green. miR-153-complementary Nfia (GenBank:
NM_001122952) and Nfib (GenBank: NM_008687) 30 UTR sequences are highlighted in red.
(B) Microarray analysis indicating the decrease of Nfia/b expression by miR-153 OE in TNs. The microarray contained two probes for Nfia
and five probes for Nfib.
(C) Reduction of NFIA/B protein expression by miR-153 OE in SNs and TNs was confirmed by western blot analysis.
(D) Dual-luciferase reporter assays were performed to investigate the interaction between miR-153 and Nfia/b 30 UTRs by using reporter
constructs containing putative miR-153 binding sites (NIFA/B) and mutated miR-153 binding sites (NFIA/B-Mu). Data are from three
independent experiments with triplicate measurements. Firefly luciferase (FL) activity was normalized to Renilla luciferase (RL) activity as
an internal control.
(E) Immunocytochemistry of differentiated TNs co-transduced with miR-153 and NFIA- and/or NFIB-KOr-expressing lentivirus vectors.
Lentivirus infection and neurosphere differentiation were performed as described in Figure 1. Single and combinatorial infections of NFIA-
and NFIB-KOr vectors were conducted at the same multiplicity of infection.
(F) The miR-153 OE-induced anti-gliogenic phenotype was rescued partially and fully by single and combinatorial NFIA and NFIB OE,
respectively. Scale bar, 50 mm.
(G) qPCR analysis of mature miR-153 and Nfia/b expression levels in developing NSPCs from Nestin-EGFP mouse forebrains at E10.5, E11.5,
and E12.5. Expression levels are presented as fold differences relative to that in E10.5 telencephalon.
(H) Reduction of NFIA/B by miR-153 OE in the VZ/SVZ of mouse embryonic cortex. miR-LacZ- and miR-153-expressing plasmid vectors were
transfected into NSPCs in the E15.5 mouse cortex by IUE and processed for NFIA/B immunohistochemistry at E17.5. Transfected cells are
circled in white. Scale bar, 20 mm.
Data in (D), (F), and (G) represent the mean ± SD (n = 3 independent experiments; *p < 0.05, **p < 0.01).
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Orange (KOr) expression. Combined expression of NFIA
and NFIB with the same dosage as NFIA or NFIB OE alone
resulted in an almost complete rescue of the astrocytic
phenotype (Figures 5E and 5F). Therefore, the function of
NFIA andNFIB in the regulation of astrogliogenesis appears
to be additive, despite their similar protein sequences and
functions (Barry et al., 2008; das Neves et al., 1999; Nami-
hira et al., 2009; Piper et al., 2010, 2014). Simultaneous
NFIA/B expression, therefore, seems to be essential for
normal astrogliogenesis. Taking all of the in vitro data
together, these experiments indicate that suppression of as-
trocytic differentiation of NSPCs is caused by miR-153-
mediated downregulation of both Nfia and Nfib as direct
miR-153 targets, at least in part.
We next investigated the correlation between miR-153
and Nfia/b in developing NSPCs in vivo by performing
RT-qPCR analysis of these genes in FACS-purified NSPCs
derived from the embryonic telencephalon and cortex of
E10.5–E12.5 Nestin-EGFP mice. As expected from our
in vitro results (Figures 1B and 5C; Figure S3), temporal
changes in miR-153 and Nfia/b expression were inversely
correlated in developing NSPCs (Figure 5G). Furthermore,
expression levels of NFIA and NFIB were increased dramat-
ically in E12.5 VZ cells compared with E11.5 VZ cells (Fig-
ures S6D and S6E). Next, to assess whether miR-153 targets
Nfia/b in vivo, the miR-153 expression vector was electro-
porated into the E15.5 mouse cortex, and NFIA/B expres-
sion was immunohistochemically examined at E17.5.
miR-153 OE clearly reduced the expression levels of both
factors in a cell-autonomous fashion (Figure 5H), suggest-
ing that miR-153 downregulation is required for increased
NFIA and/or NFIB content in the developing cortex.
Stimulation of Astrogliogenesis and NFIA/B
Expression via miR-153 Inhibition
Finally, we investigated the role of miR-153 in gliogenesis
by inhibiting miR-153 function with the aid of a synthetic
tough decoy (S-TuD) system that can suppress specific
miRNA activity (Haraguchi et al., 2012). S-TuD inhibition
of miR-153 was first tested by performing a luciferase re-
porter assay that employed a reporter construct containing
three tandem repeats of the complementary target seq-
uence of miR-153 as a miRNA sensor. Cotransfection of
the miR-153 expression vector and the S-TuD complemen-
tary to miR-153 (S-TuD-153) rescued the miR-153-medi-
ated reduction of reporter activity in HEK293A cells
(Figure 6A). Moreover, transfection of S-TuD-153 into
ESC-derived PNs significantly increased the number of
GFAP+ astrocytes (Figures 6B and 6C), indicating that
miR-153 is required to prevent precocious gliogenesis.
The involvement of miR-153 in the regulation of NFIA
and/or NFIB expression in developing NSPCs was further
explored by electroporating S-TuD-153 into themouse cor-372 Stem Cell Reports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Atex at E10.5, and we assessed NFIA/B protein expression
levels at E11.5, when their expression is mostly undetect-
able with our antibodies in the VZ (Figure S6D). S-TuD-
153 induced a significant increase in NFIA/B content in
the cortical VZ (Figures 6D and 6E). Next, to assess whether
miR-153 inhibition can induce competence change of
NSPCs to respond to gliogenic signals, we cultured cortical
NSPCs from mouse E11.5 brains electroporated with S-
TuD-153 at E10.5 in the presence of the gliogenic cytokines
LIF and BMP2 for 4 days. The introduction of S-TuD-153
significantly increased the number of GFAP+ astrocytes
(Figures 6F and 6G) and decreased the number of SOX1+
progenitor cells (Figure S7). Moreover, co-electroporation
of S-TuD-153 and the LIF expression vector into the E10.5
mouse cortex induced ectopic expression of GFAP at
E12.5, whereas no expression of GFAP was detected at all
in any other electroporations, including S-TuD-153 only
and a combination of the LIF expression vector and control
S-TuD (Figure 6H). These results indicate that miR-153 is
involved in the modulation of the acquisition of gliogenic
competence by developing NSPCs via the regulation of
NFIA and NFIB.DISCUSSION
Here we demonstrated that miR-153 plays a crucial role in
the regulation of acquisition of gliogenic competence by
NSPCs as an upstream regulator of NFIA/B. The inverse cor-
relation of miR-153 and NFIA/B expression revealed here is
indicative of the requirement of miR-153 for the preven-
tion of gliogenesis by NSPCs in the early neurogenic period
and strongly suggests that the regulation of NFIA/B expres-
sion levels by miR-153 is one of the critical factors for the
timing of astrogliogenesis (Figure 7). Importantly, miR-
153 has been shown to be able to regulate the expression
of NFIA/B in the immature brain during the course of this
study (Tsai et al., 2014). However, the spatiotemporal
expression of miR-153 in the developing CNS, the LOF
analysis of miR-153 to clarify its physiological function in
the developing CNS, and the association of miR-153 with
astrogliogenesis have not been reported.
Although NFIB participates critically in the regulation of
NSPC differentiation and astrogliogenesis during CNS
development (Steele-Perkins et al., 2005), no information
was available previously regarding the regulation of NFIB
expression in developing NSPCs, although a recent report
demonstrated miR-153-facilitated control of NFIA/B levels
in the fetal brain (Tsai et al., 2014). Here we demonstrated
independently the direct regulation of NFIA/B expression
by miR-153 in developing NSPCs. The synergistic actions
of the two factors to rescue the anti-gliogenic phenotype
provoked by miR-153 in NSPCs (Figures 5E and 5F) anduthors
Figure 6. Inhibition of miR-153-Acceler-
ated Progression of NSPC Development
(A) HEK293A cells were cotransfected with a
miR-153 sensor vector containing three
tandem miR-153 binding sequences down-
stream of a luciferase reporter gene with the
miR-153 inhibitor S-TuD-153 RNA or with a
miR-153- or miR-LacZ-expressing plasmid
vector without S-TuD-153 RNA. Luciferase
activities were then measured. S-TuD-153
successfully abolished the suppressive ef-
fect of miR-153 on miR-153 sensor vector
reporter activity. FL activity was normalized
to RL activity as an internal control.
(B and C) Dissociated EB cells were trans-
fected with an S-TuD-negative control (NC)
or miR-153 and cultured for 2 days in the
presence of fibroblast growth factor 2
(FGF2). The cells were then allowed to
differentiate in the presence of LIF for
5 days. S-TuD-153 accelerated the onset of
astrogliogenesis in the early NSPCs. Scale
bar, 50 mm.
(D and E) IUE of S-TuD-153 into the E10.5
cortex increased the expression of NFIA/B.
Brains were processed for immunocyto-
chemistry of NFIA (D) and NFIB (E) 24 hr
post-electroporation. Arrowheads indicate
NFIA+ or NFIB+ cells. Scale bars, 20 mm.
(F and G) In vitro differentiation of cortical
NSPCs after IUE of S-TuDs at E10.5 in vivo.
Cortices from E11.5 mouse embryos were
dissociated and cultured in the presence of
LIF (10 ng/ml) and BMP2 (100 ng/ml) for
4 days. A significant increase of GFAP+ as-
trocytes by introduction of S-TuD-153
compared with that of S-TuD-NC was
observed. Scale bar, 50 mm.
(H) Precocious expression of GFAP was
induced by a combination of miR-153 inhi-
bition and LIF overexpression. E10.5 mouse
brains were electroporated with S-TuDs and/
or a LIF expression vector (pCAGGS-LIF) at
the cortical VZ and processed for immuno-
cytochemistry of GFAP at E12.5. Arrowheads
indicate GFAP+ cells. Scale bars, 20 mm.
Data in (A), (C), and (G) represent the
mean ± SD (n = 3 independent experiments;
*p < 0.05, **p < 0.01).the astrogliogenesis defects generated in various NFIA/B
LOF analyses (Figure S5; das Neves et al., 1999; Shu et al.,
2003; Steele-Perkins et al., 2005) suggest that NFIA and
NFIB function cooperatively yet in parallel to promote as-
trogliogenesis. For instance, NFIA/B may modify different
transcriptional targets to achieve this goal. NFIB is aStem Celldemonstrated transcriptional repressor of the Polycomb
group (PcG) protein Ezh2, which is itself required to pre-
vent the premature onset of gliogenesis in developing
NSPCs (Pereira et al., 2010; Piper et al., 2014). For its part,
NFIA functions as a transcriptional activator for several
gliogenic genes, including Gfap. Notably, EZH2 binds toReports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Authors 373
Figure 7. Schematic Showing the Role of miR-153 in the Timing
of NSPC Gliogenesis during Development
In the early neurogenic stage, miR-153 is highly expressed and
prevents competence change for the initiation of gliogenesis by
repressing NFIA/B expression. Downregulation of miR-153 causes
increased levels of NFIA/B and the acquisition of gliogenic
competence so that NSPCs can respond to gliogenic signals at
midgestation stage. The downregulation of miR153 may stem from
a progression of NSPCs into the gliogenic phase, facilitated by
increased NFI levels, which may, in turn, contribute to the ‘‘one-
way street’’ nature of this developmental process.the Gfap promoter together with chromodomain helicase
DNA binding protein 4 to repress Gfap transcription (Spar-
mann et al., 2013). Therefore, NFIB-mediated repression
of EZH2 and removal from the Gfap promoter, as well as
direct transcriptional activation of Gfap by NFIA, probably
contribute to the procurement of glial gene expression.
Based on the above evidence, miR-153, which downre-
gulates both NFIA and NFIB, likely acts to fine-tune glio-
genic timing. The increase in undifferentiated NSPCs
with a limited enhancement of neurogenesis by miR-153
OE in vitro and in vivo (Figures 3 and 4A–4G) as well as
the decrease in progenitor cells by S-TuD-153 (Figure S7)
may also be explained by the inhibition of NFIA/B. To
this end, NFIA is required for the differentiation of astro-
cyte precursors (Deneen et al., 2006), and knockout mice
for any of these genes exhibit an increase in undifferenti-
ated progenitors in the perinatal brain (Pereira et al., 2010;
Piper et al., 2010, 2014). Nonetheless, there is a clear
phenotypic difference in NSPC proliferation between
these Nfi knockout mice and miR-153 OE in that prolifer-
ation is increased in the former and unaltered in the latter
(Figures 4H–4J). This may occur because NFIs function to
both inhibit proliferation and induce differentiation. In
addition, other unidentified miR-153 targets may account
for the difference. In fact, miR-153 reportedly plays both
positive and negative roles in cell proliferation depending
on the cellular context (Wu et al., 2013; Zhao et al., 2013).
Alternatively, the difference may be caused by difference
of NFIA/B protein levels and/or duration of their LOF.
Regardless, because miR-153 expression decreases dramat-
ically before the onset of gliogenesis in the developing374 Stem Cell Reports j Vol. 5 j 365–377 j September 8, 2015 j ª2015 The Acortex (Figures 2B–2D and 5G), the primary role for
miR-153 in the modulation of the neurogenesis-to-glio-
genesis switch in the developing CNS is probably to block
precocious gliogenesis via repression of NFIA/B expression
in NSPCs.
Elucidation of the regulatory mechanisms for miR-153
expression is required to further understand the neurogen-
esis-to-gliogenesis switch. Although NFIA OE decreased
miR-153 expression in ESC-derived NSPCs (Figure 1B), no
significant change was observed in LOF studies of NFIA
and NFIB in vitro and in Nfia knockout mice (Figure S8).
Most likely, the reduction in miR-153 levels by NFIA OE
stems from an enhanced transition to the gliogenic phase.
In agreement, miR-153 expression is maintained in the
VZ of the LGE (Figure 2C), which becomes the highly
neurogenic adult SVZ, where only subpopulations of SVZ
astrocytes and neuroblasts express NFIA/B (Plachez et al.,
2012).
This study indicates that miR-124 and miR-219 may also
be involved in the neurogenesis-to-gliogenesis switch by
NSPCs. miR-124 promotes neurogenesis via downregula-
tion of several genes (Sox9, Scp1, and Ezh2) that are positive
regulators of gliogenesis or negative regulators of neuro-
genesis in the developing and adult brain (Neo et al.,
2014; Papagiannakopoulos and Kosik, 2009; Visvanathan
et al., 2007). Depression of the neurogenic cascade,
including miR-124-mediated regulation, may participate
in the neurogenesis-to-gliogenesis switch. miR-219 stimu-
lates both neurogenesis and gliogenesis during CNS devel-
opment in the zebrafish (Hudish et al., 2013) and terminal
differentiation of oligodendrocytes in the mouse (Dugas
et al., 2010; Zhao et al., 2010). In our work, however,
miR-219 OE only suppressed astrocytic differentiation of
NSPCs in a limited developmental time window (Figures
1C–1F). The region-specific expression pattern of miR-219
in the early embryonic CNS (Figure S2) suggests that miR-
219 functions differently in different CNS regions.
We showed recently thatmiR-17/106 inhibits gliogenesis
by NSPCs via downregulation of p38 MAP kinase down-
stream of COUP-TFs (Naka-Kaneda et al., 2014). miR-17
OE in highly gliogenic quaternary neurospheres from
ESCs even induced a marked restoration of neuropotency,
which is unlike the miR-153 OE phenotype. Because the
expressions of both Nfia and Nfib are not changed signifi-
cantly by Coup-tfI/II-KD in developing NSPCs (Naka et al.,
2008), the miR-17/106-p38 axis and the miR-153-NFIA/B
axis may function in parallel to control the neurogenesis-
to-gliogenesis transition.
In conclusion, our results, together with those of others,
indicate that the neurogenesis-to-gliogenesis switch in
developing NSPCs is governed by precise control of the
expression of many different proteins by a number of miR-
NAs in a multi-layered regulatory cascade.uthors
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treatment, neurosphere formation, and neurosphere differentia-
tion were performed as described previously (Naka-Kaneda et al.,
2014).
Lentivirus Preparation
Lentivirus vectors were prepared as described previously (Naka
et al., 2008). Details, including the sequences of the shRNAs and
the artificial microRNAs, are described in the Supplemental Exper-
imental Procedures and Tables S1–S5.
Animals
Animal experiments were performed with Institute of Cancer
Research (ICR) strain mice (CD-1) and Nfia-deficient mice (Shu
et al., 2003). All experimental procedures were approved by the
Ethics Committee of Keio University (approval no. 09091) and
were in accordance with the Guide for the Care and Use of Labora-
tory Animals (NIH).
Statistical Analyses
At least three independent experiments were included in each sta-
tistical analysis. Statistical significance was determined via two-
tailed t test. In all cases, p < 0.05 was considered statistically
significant.
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